CAS No.: 1262036-50-9
LY2886721 Catalog No. CSN17134
Synonyms: β-Secretase
LY2886721 is an BACE inhibitor used for the treatment of Alzheimer's Disease.
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点 NCT01561430 Alzheimer's Disease Phase 1 Phase 2 Terminated(Study terminated du... more >>e to abnormal liver biochemical tests in some participants.) Collapse << - - NCT01561430 - - Terminated(Study terminated du... more >>e to abnormal liver biochemical tests in some participants.) Collapse << - - NCT01807026 Alzheimer Disease ... more >> Healthy Volunteers Collapse << Phase 1 Completed - United States, Utah ... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Salt Lake City, Utah, United States Collapse << - 更多
- 参考文献
- [1] May PC, Willis BA, et al. The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans. J Neurosci. 2015 Jan21;35(3):1199-210.
- [2] Townsend M. When will Alzheimer's disease be cured? A pharmaceutical perspective. J Alzheimers Dis. 2011;24 Suppl 2:43-52.
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 1262036-50-9 | 储存条件 |
|
|
| 分子式 | C18H16F2N4O2S | 运输 | 蓝冰 | |
| 分子量 | 390.41 | 别名 | β-Secretase |
